Article Sidebar
Published:
Sep 6, 2024DOI:
10.4314/tjpr.v23i7.6Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Anti-atherogenic effect of Channa striatus fish extract in high cholesterol-fed rabbits
Abstract
Purpose: To determine the effect of aqueous extract of Channa striatus on plasma lipids concentrations, pro-inflammatory cytokines levels, adhesion molecules and arterial plaque formation in cholesterol-fed rabbits.
Methods: New Zealand rabbits (n = 30, females) were divided into five groups of six rabbits each as follows: cholesterol control group (0.5 % cholesterol); normal control group (normal diet), positive control group (0.5 % cholesterol + 5 mg/kg atorvastatin); and treatment groups (0.5% cholesterol + 250 mg/kg or 500 mg/kg C. striatus extracts, respectively) for 6 weeks. Blood was taken every 2 weeks and analyzed for total cholesterol (TC), low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), triglyceride (TG), tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β). Atherogenic index (AI) was calculated based on LDL:HDL ratio.
Results: Cholesterol feeding for 6 weeks resulted in significantly increased TC, LDL, HDL, AI, TG, TNFα and IL-1β when compared to C. striatus-fed rabbits. Serum LDL was 26.34 ± 1.43 mmol/L in C. striatus group to 30.52 ± 0.82 mmol/L in cholesterol group (p < 0.05). C. striatus extract (250 mg/kg) increased HDL by approximately 400 % (6.23 ± 1.76 mmol/L from 0.72 ± 0.18 mmol/L), decreased AI value (4.6 in C. striatus group to 10.4 in cholesterol group). Also, IL-1β and TNF-α concentration also significantly (p < 0.05) reduced with C. striatus administration. Interestingly, down-regulation of ICAM-1 and VCAM-1 expression and reduced plaque formation were observed with C. striatus feeding.
Conclusion: Channa striatus extract is effective in reducing atherogenesis. This could be due to the high HDL level produced in 250 mg/kg dose group, and strongly suggests the significance of HDL in preventing atherogenesis even if other lipid profiles remain unchanged
